You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Baxter
Johnson and Johnson
Express Scripts
McKesson

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: upadacitinib


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

upadacitinib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abbvie Inc RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-2306-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30)
Abbvie Inc RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-2306-70 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Express Scripts
Mallinckrodt
Dow
Boehringer Ingelheim